Hyperlipidemia among Patients with type 2 Diabetes Mellitus in Al-Nasiriya City

Authors

  • Zainab Jamal Hamoodah
  • Ihab Rasmi Hasan
  • Sarah Ajwad Mejbel
  • Abeer Talib Ali

DOI:

https://doi.org/10.47750/pnr.2022.13.S03.153

Keywords:

Diabetes Mellitus (DM), Diabetic Dyslipidemia, HbA1c, FBS, TC, HDL, LDL, TG, VLDL.

Abstract

Diabetes mellitus is a set of metabolic disorders that result in persistent diseases characterised by excessive blood sugar because of the lack of manufacturing of insulin, a hormone responsible for regulating sugar levels. This study became carried out on 42 (24 female, 18 male) noninsulin-dependent diabetics without a control group for comparison. The information had been obtained from November 2021 to February 2022 from the clinical data of the Diabetes Center in the Nasiriyah city. The exclusion criteria had been patients with type 1 diabetes who have been already taking lipid-decreasing drugs. Patients had been categorized into two groups based on glycated hemoglobin, the good glycemic control group having less than 7.0% and the poor glycemic control group having more than 7.0%. Data have been analyzed in the use of the (SPSS) program (p-value ≤0.05) and the superiority of dyslipidemia in diabetic patients was 43% amongst men and 57% amongst females. This study evaluated the relationship amongst glycemic control and lipid profile amongst diabetic patients. Evaluation of data by kind shows gender that there may be no significant difference in blood sugar parameters in addition to lipid level amongst males and females except for HDL values that are higher in females.

Downloads

Published

2022-09-22

Issue

Section

Articles

How to Cite

Hyperlipidemia among Patients with type 2 Diabetes Mellitus in Al-Nasiriya City. (2022). Journal of Pharmaceutical Negative Results, 993-998. https://doi.org/10.47750/pnr.2022.13.S03.153